Table 3 Univariable and multivariable Cox regression analysis for recurrence-free survival (n = 503)
Unadjusted | Adjusted | |||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (years) | ||||
< 40 | 1 (ref) | 1 (ref) | ||
40–49 | 0.81 (0.51–1.16) | 0.177 | 0.96 (0.69–1.28) | 0.476 |
50–59 | 0.67 (0.49–0.93) | 0.228 | 0.74 (0.52–1.06) | 0.137 |
≥ 60 | 0.59 (0.38–0.86) | 0.039 | 0.61 (0.41–1.02) | 0.062 |
ASA physical status | ||||
I | 1 (ref) | 1 (ref) | ||
II | 1.19 (0.88–1.36) | 0.571 | 1.23 (0.93–1.44) | 0.274 |
III | 1.89 (1.11–3.24) | 0.035 | 2.14 (1.05–3.63) | 0.042 |
TNM stage | ||||
1 | 1 (ref) | 1 (ref) | ||
2 + 3 | 3.72 (2.18–5.65) | < 0.001 | 3.48 (1.96–5.47) | 0.009 |
Surgery type | ||||
Breast conservation | 1 (ref) | 1 (ref) | ||
Mastectomy | 2.11 (1.48–2.81) | 0.028 | 1.77 (1.21–2.36) | 0.041 |
Oestrogen receptor | ||||
Negative | 1 (ref) | 1 (ref) | ||
Positive | 0.62 (0.48–0.81) | 0.068 | 0.77 (0.51–1.25) | 0.236 |
Progesterone receptor | ||||
Negative | 1 (ref) | 1 (ref) | ||
Positive | 0.59 (0.46–0.77) | 0.055 | 0.92 (0.69–1.25) | 0.526 |
HER2 | ||||
Negative | 1 (ref) | 1 (ref) | ||
Positive | 1.37 (0.88–2.04) | 0.114 | 1.22 (0.80–1.83) | 0.331 |